[Potentials of the modern pathogenetic treatment of immune glomerulonephritis].
D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000209:etiology; D005923:Glomerulosclerosis, Focal Segmental / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007154:Immune System Diseases / Q000188:drug therapy* / Q000209:etiology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000209:etiology; D011379:Prognosis; D013290:Streptococcal Infections / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D000925:Anticoagulants; D007166:Immunosuppressive Agents
Vuzmozhnosti na suvremennoto patogenichno lechenie na immunnite glomerulonefriti.